Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
More about Open Access at the CrickAuthors list
Nikhil Faulkner Kevin Ng Mary Wu Ruth Harvey Marios Margaritis Stavroula Paraskevopoulou Catherine Houlihan Saira Hussain Maria Greco William Bolland Scott Warchal Judith Heaney Hannah Rickman Moria Spyer Daniel Frampton Matthew Byott Tulio de Oliveira Alex Sigal Svend Kjaer Charles Swanton Sonia Gandhi Rupert Beale Steve Gamblin John Mccauley Rodney Stuart Daniels Michael Howell David LV Bauer Eleni Nastouli SAFER Investigators George Kassiotis Toggle all authors (30)
Abstract
Background: The degree of heterotypic immunity induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains is a major determinant of the spread of emerging variants and the success of vaccination campaigns, but remains incompletely understood. Methods: We examined the immunogenicity of SARS-CoV-2 variant B.1.1.7 (Alpha) that arose in the United Kingdom and spread globally. We determined titres of spike glycoprotein-binding antibodies and authentic virus neutralising antibodies induced by B.1.1.7 infection to infer homotypic and heterotypic immunity. Results: Antibodies elicited by B.1.1.7 infection exhibited significantly reduced recognition and neutralisation of parental strains or of the South Africa variant B.1.351 (Beta) than of the infecting variant. The drop in cross-reactivity was significantly more pronounced following B.1.1.7 than parental strain infection. Conclusions: The results indicate that heterotypic immunity induced by SARS-CoV-2 variants is asymmetric.
Full text links
Publisher website (DOI) 10.7554/eLife.69317
Figshare View on figshare
Europe PubMed Central 34323691
Pubmed 34323691
Keywords
Related topics
- Tumour Biology
- Structural Biology & Biophysics
- Stem Cells
- Signalling & Oncogenes
- Neurosciences
- Model Organisms
- Metabolism
- Infectious Disease
- Immunology
- Human Biology & Physiology
- Genome Integrity & Repair
- Genetics & Genomics
- Computational & Systems Biology
- Chemical Biology & High Throughput
- Cell Cycle & Chromosomes
- Cell Biology
Type of publication